News – Page 120 – Endpoints News

Cognition Therapeutics' stock sinks on Phase 2 Alzheimer’s data

9 months ago

Collegium pays $525M to buy ADHD company; FDA delays Syndax decision

9 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

9 months ago

WuXi AppTec sees US revenue decline amid Biosecure threat

9 months ago

Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

9 months ago

AstraZeneca’s fixed-duration Calquence combo succeeds in Phase 3 blood cancer test

9 months ago

vTv Therapeutics' diabetes drug program hit with clinical hold from FDA

9 months ago

Anavex’s new analysis of its Alzheimer’s pill shows mixed results

9 months ago

Mapping GLP-1 game plans; Q2 earnings highlights; J&J vets regroup at startup; and more

9 months ago

Compounded weight loss drugs have resulted in misdosing, hospitalizations, FDA warns

9 months ago

Among pharma CEOs, the IRA now and the IRA later get very different reactions

9 months ago

Pfizer and BioNTech say GSK's Covid patent suit is 'groundless'

9 months ago

Updated: Bristol Myers restarts radiopharmaceutical Phase 3 trial

9 months ago

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

9 months ago

Cue Biopharma prioritizes autoimmune pipeline, axes a quarter of staff to save cash

9 months ago

ProMIS announces PIPE up to $122M; Confo raises €60M in Series B

9 months ago

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

9 months ago

Calliditas claims mid-stage win for rare liver disease drug

9 months ago

FDA approves Sun Pharma's JAK inhibitor Leqselvi for hair loss in adults

9 months ago

Westlake's non-opioid pain startup Latigo gets new leader; Ron Cooper lands next CEO gig at enGene

9 months ago

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

9 months ago

FDA advisors call for better studies of immunotherapy around lung cancer surgery, but give AstraZeneca a pass

9 months ago

EU panel follows FDA’s lead on Wegovy, recommending use to prevent cardiac events

9 months ago

Ipsen loses legal appeal over whether blockbuster cancer treatment is a drug or biologic

9 months ago

First page Previous page 117 118 119120121 122 123 Next page Last page